News
Providing Unbiased & Inclusive Information from the Entire Industry
Sociedelic
US Govt Agency Admits That Marijuana Extracts Can Kill Cancer Cells – Sociedelic
Marijuana can help in the fight against cancer, according to the United States Federal Government. Say what? Yes, thatÕs the same United States Federal
Read MoreSociedelic
Study Looks At Long-Term Effects Of Ibogaine On Addiction – Sociedelic
Ibogaine has shown remarkable proficiency helping people beat drug addictions. The substance, derived from the roots of the African iboga shrub, is
Read MoreSociedelic
Could Ibogaine Be A Promising New Treatment For ParkinsonÕs Disease? – Sociedelic
A research team at Columbia University soon hopes to show whether or not ibogaine, an extract of iboga Ñ a psychoactive West-African plant medicine Ñ may
Read MoreSociedelic
How Ibogaine Fights Stubborn Prescription Painkiller Addictions – Sociedelic
When he was 13 years old, Jeremy SuttonÕs* mother passed away, and he began drinking alcohol to help cope with the trauma. Liquor became cocaine and
Read MoreSociedelic
Federal Cancer Institute Acknowledges Cancer-Fighting Properties of Cannabis – Sociedelic
The National Cancer Institute acknowledged in a recent report that marijuana has impressive tumor fighting properties and can help reduce rates of various
Read MoreSociedelic
An Introduction To The Endocannabinoid System – Sociedelic
As you read this review of the scientific literature regarding the therapeutic effects of cannabis and cannabinoids, one thing will become quickly
Read MoreSociedelic
Study: Patients Replace Prescription Drugs With Cannabis – Sociedelic
Patients with legal access to medical marijuana reduce their consumption of conventional pharmaceuticals, according to a demographic review of patient
Read MorePsychedelic Times
Dancing With the Ancestors: Traditional Iboga Use in Bwiti Culture – Psychedelic Times
The people of the Bwiti religion in west AfricaÕs Gabon have used the entheogenic iboga plant for over a century for rituals, healing, and rites of passage.
Read MoreSociedelic
Ayahuasca Vs. Iboga – Sociedelic
In comparing Iboga and Ayahuasca the most difficult part is finding any common ground at all. They are as different as two experiences could be, though
Read MoreSociedelic
8 Sacred Herbs To Aid The Lucid Dreamer – Sociedelic
The plants of our world are the fulcrum of life as we know it. Bestowing us with health, sustenance, and expansion of the mind's functionality, we owe our
Read MoreSociedelic
A Passion For Powerful Plants And People – Sociedelic
Plantswoman and shamanic practitioner Sitaramaya Sita created Visionary Convergence to find common ground and cultivate community and awareness for
Read MoreSociedelic
7 People Who Say They Owe Their Huge Success To Psychedelics – Sociedelic
DonÕt do drugs! TheyÕll lead you down the path to perdition! ThatÕs the message beaten into our heads from our earliest years. But not everybody listens,
Read MoreThe Daily Beast
Mental HealthÕs New (Old) Secret Weapon: Psychedelics
A comprehensive analysis of the use of psychedelics for anxiety, PTSD, and addiction shows serious medical potential for the drugs.
Read MoreDaily Mail
Stone Age man ate mushrooms: Oldest evidence for fungi in the human diet discovered in 19,000-year-old tooth plaque | Daily Mail Online
Anthropologists at the Max Planck Institute in Leipzig, Germany, found spores from several species of mushrooms in the dental plaque of the Red Lady of El Mirn found in...
Read MoreMedium
The Drug Revolution That No One Can Stop | by Mike Power | Matter | Medium
Designing your own narcotics online isnÕt just easyÑit can be legal too. How do we know? We did it.
Read MoreNature
No link found between psychedelics and psychosis | Nature
In large US survey, users of LSD and similar drugs were no more likely to have mental-health conditions than other respondents.
Read MoreScience in the News | Harvard
Worth the trip: psychedelics as an emerging tool for psychotherapy – Science in the News
As your eyes close, a kaleidoscopic vision of pattern, color, and sense of deep meaning engulfs your entire field of experience. Thirty minutes ago you were given a controlled dose...
Read MoreLive Science
Prehistoric High Times: Early Humans Used Magic Mushrooms, Opium | Live Science
Opium, "magic" mushrooms and other psychoactive substances have been used since prehistoric times all over the world, according to a new review of archaeological findings.
Read MorePubMed Central (PMC)
Evidence of a link between taboos and sacrifices and resource scarcity of ritual plants – PMC
One of the main obstacles for the mainstreaming of religious traditions as tools for the conservation of nature is the limited applicability of research results in this field. We documented...
Read MoreResearch Gate
DMT research from 1956 to the end of time
From a representative sample of a suitably psychedelic crowd, youÕd be hard pressed to find someone who couldnÕt tell you all about Albert HofmannÕs enchanted bicycle ride after wallowing what...
Read MorePsilocybin Ð Summary of knowledge and new perspectives – ScienceDire ...
Psilocybin, a psychoactive alkaloid contained in hallucinogenic mushrooms, is nowadays given a lot of attention in the scientific community as a reseaÉ
Read MorePsilocybe Cubensis and Other Types of Magic Mushrooms You Should Know ̵ ...
Magic mushrooms are so incredible and mysterious, from the beautiful experiences they occasion to the mystical compounds that they naturally produce. But
Read MorePsilocybin Treatment for Major Depression Effective for Up to a Year for Mo ...
Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.
Read MoreBiosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DM ...
N,N-dimethyltryptamine (DMT), a psychedelic compound identified endogenously in mammals, is biosynthesized by aromatic-L-amino acid decarboxylase (AADC) and indolethylamine-N-methyltransferase (INMT). Whether DMT is biosynthesized in the mammalian brain is unknown. We investigated brain expression of INMT transcript in rats and humans, co-expression of INMT and AADC mRNA in rat brain and periphery, and brain concentrations of DMT in rats. INMT transcripts were identified in the cerebral cortex, pineal gland, and choroid plexus of both rats and humans via in situ hybridization. Notably, INMT mRNA was colocalized with AADC transcript in rat brain tissues, in contrast to rat peripheral tissues where there existed little overlapping expression of INMT with AADC transcripts. Additionally, extracellular concentrations of DMT in the cerebral cortex of normal behaving rats, with or without the pineal gland, were similar to those of canonical monoamine neurotransmitters including serotonin. A significant increase of DMT levels in the rat visual cortex was observed following induction of experimental cardiac arrest, a finding independent of an intact pineal gland. These results show for the first time that the rat brain is capable of synthesizing and releasing DMT at concentrations comparable to known monoamine neurotransmitters and raise the possibility that this phenomenon may occur similarly in human brains.
Read MorePilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-S ...
Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the…
Read MorePsilocybin Treatment for Major Depression Effective for Up to a Year for Mo ...
Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.
Read MorePsilocybin Ð Summary of knowledge and new perspectives – ScienceDire ...
Psilocybin, a psychoactive alkaloid contained in hallucinogenic mushrooms, is nowadays given a lot of attention in the scientific community as a reseaÉ
Read MorePsilocybe Cubensis and Other Types of Magic Mushrooms You Should Know ̵ ...
Magic mushrooms are so incredible and mysterious, from the beautiful experiences they occasion to the mystical compounds that they naturally produce. But
Read MoreBiosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DM ...
N,N-dimethyltryptamine (DMT), a psychedelic compound identified endogenously in mammals, is biosynthesized by aromatic-L-amino acid decarboxylase (AADC) and indolethylamine-N-methyltransferase (INMT). Whether DMT is biosynthesized in the mammalian brain is unknown. We investigated brain expression of INMT transcript in rats and humans, co-expression of INMT and AADC mRNA in rat brain and periphery, and brain concentrations of DMT in rats. INMT transcripts were identified in the cerebral cortex, pineal gland, and choroid plexus of both rats and humans via in situ hybridization. Notably, INMT mRNA was colocalized with AADC transcript in rat brain tissues, in contrast to rat peripheral tissues where there existed little overlapping expression of INMT with AADC transcripts. Additionally, extracellular concentrations of DMT in the cerebral cortex of normal behaving rats, with or without the pineal gland, were similar to those of canonical monoamine neurotransmitters including serotonin. A significant increase of DMT levels in the rat visual cortex was observed following induction of experimental cardiac arrest, a finding independent of an intact pineal gland. These results show for the first time that the rat brain is capable of synthesizing and releasing DMT at concentrations comparable to known monoamine neurotransmitters and raise the possibility that this phenomenon may occur similarly in human brains.
Read MorePilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-S ...
Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the…
Read More